Wondering how much PT-141 should I inject? The FDA-approved dose is 1.75 mg subcutaneously, once per 24 hours. See the full dosing, timing, and safety picture.
The FDA-approved dose of PT-141 (bremelanotide, sold under the brand name Vyleesi) is 1.75 mg injected subcutaneously, usually into the abdomen or thigh, at least 45 minutes before anticipated sexual activity. The label caps use at one injection per 24 hours and no more than eight injections per month. There is no approved higher dose, and any change to that number should come from a licensed prescriber rather than a forum thread.
What the FDA Label Says About PT-141 Dosing
Bremelanotide was approved in 2019 for premenopausal women with hypoactive sexual desire disorder, or HSDD. The approved regimen is fixed rather than flexible: 1.75 mg, subcutaneously, as needed.
The label limits are straightforward:
- One injection per 24 hours.
- No more than 8 injections per month.
- Inject at least 45 minutes before sexual activity.
- Rotate sites between the abdomen and the thigh.
PT-141 is not FDA-approved for men, and it is not approved for postmenopausal women. Use outside those parameters is off-label, which means the amount becomes a clinical judgment call instead of a label instruction.
PT-141 Injection Doses Compared
Most of the numbers circulating online sit in a narrow range, but they are not equal in terms of evidence or regulatory status.
| Dose | Where It Comes From | Frequency | Notes |
|---|---|---|---|
| 1.75 mg SC | FDA-approved label (Vyleesi) | Once per 24 hours, max 8 per month | The only dose with regulatory approval |
| 1.0 to 1.75 mg | Compounded and clinic protocols | Per prescriber instructions | Compounded PT-141 is not FDA-approved |
| 2 mg | Older research and anecdotal reports | Single dose per session | Higher rates of nausea and blood pressure rise |
| Above 2 mg | Not recommended | Not established | No evidence of better results, more side effects |
Raising the dose does not reliably raise the response. In trials, 1.75 mg produced the best balance of benefit and tolerability, and higher amounts increased nausea without adding much in return.
Why More PT-141 Is Not Better
PT-141 is a melanocortin receptor agonist, and its side effects scale with dose. The most common complaints in clinical trials were nausea, flushing, headache, and injection site reactions.
- Nausea: reported by roughly 40% of participants at the approved dose.
- Blood pressure: a transient rise that can last up to 12 hours.
- Hyperpigmentation: dark patches on the skin, gums, or face with frequent repeat dosing.
- Vomiting and flushing: more likely as the amount climbs.
The effect on blood pressure lingers well past the sexual effect, so stacking doses within a day is not a shortcut. It mostly adds risk. PT-141 is not a cure for low desire, and it does not work for everyone who tries it.
Reconstituting and Injecting PT-141 Correctly
Compounded or research-grade PT-141 usually arrives as a lyophilized powder, so it must be mixed before injection. Sterile technique matters, and a mistake in concentration is one of the most common ways people accidentally take the wrong amount.
Anyone working through the math should also review how much bacteriostatic water to mix with pt-141, because the dilution ratio decides how many units on an insulin syringe equal 1.75 mg. A 10 mg vial mixed with 1 mL puts 1.75 mg in 17.5 units on a U-100 syringe, while the same vial mixed with 2 mL doubles the volume needed for that dose.
Basic injection steps:
- Wash your hands and swab the vial top and injection site with alcohol.
- Draw the calculated volume with a 29 to 31 gauge insulin syringe.
- Pinch the skin and inject at a 45 to 90 degree angle into the abdomen or thigh.
- Rotate sites so one area does not absorb every injection.
- Dispose of the needle in a sharps container.
Never share a vial or a syringe, and never inject a solution that looks cloudy or contains particles.
How Long PT-141 Takes to Work and How Long It Lasts
Timing expectations matter as much as the amount. Most people who search pt-141 how long does it take to work find that the onset is roughly 45 minutes to two hours after injection, which is exactly why the label says to dose at least 45 minutes ahead.
The question of how long does pt-141 last has a similarly practical answer: the noticeable effect usually runs about two to four hours, though individual responses vary. The half-life is around 2.7 hours, and blood pressure changes can persist for up to 12 hours after a single dose.
Because of that window, a second injection the same evening is not recommended.
Nasal PT-141 Is a Different Calculation
Nasal bremelanotide was studied years ago and never received FDA approval. Absorption through the nose is inconsistent, so an injection amount does not translate into a spray amount. That variability is part of why the injected product won approval and the nasal version did not.
People who want to know how to use pt-141 nasal spray should understand that the amount delivered per spray depends on the concentration of the solution and the device, not on a fixed label dose. There is no approved conversion from milligrams injected to milligrams sprayed.
Who Should Not Inject PT-141
Bremelanotide carries real contraindications, so a prescriber should screen for these before writing a prescription:
- Uncontrolled high blood pressure or known cardiovascular disease.
- Pregnancy or breastfeeding.
- Current use of nitrates or other blood-pressure-lowering medications.
- A known hypersensitivity to bremelanotide.
Men using PT-141 are using it off-label, because the drug is not approved for male use. Anyone comparing peptides, such as asking how much tesamorelin should i take a day, should treat each compound as its own drug with its own safety profile rather than assuming the dosing logic transfers.
Talking With a Clinician Before You Dose
PT-141 is a prescription product, and the right amount for one person may not be right for another. Blood pressure history, current medications, and how often someone plans to dose all change the answer.
Bring your questions to a licensed healthcare professional, including whether PT-141 is appropriate for you at all and what to do if nausea or a headache appears after an injection. If you experience chest pain, a severe headache, or signs of very low blood pressure, seek medical care right away.
Frequently Asked Questions
How much PT-141 should I inject the first time?
The first dose and the only FDA-approved dose is 1.75 mg injected subcutaneously, with no titration step in the label. You start at 1.75 mg and stay there, no more than once every 24 hours. Compounded products vary in concentration, so a prescriber should confirm the exact syringe units.
Is 2 mg of PT-141 stronger than 1.75 mg?
It is a higher amount, but that does not translate into a better effect. Trials showed more nausea, flushing, and blood pressure elevation at higher doses without a meaningful gain in benefit. The 1.75 mg approved dose is what the evidence supports.
Can I inject PT-141 more than once a day?
No. The label limits use to one injection per 24 hours and no more than eight injections per month. Repeated dosing within a day increases the chance of nausea, blood pressure changes, and skin hyperpigmentation.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.